KYTHERA Commences Share Offering - Quick Facts

(RTTNews) - KYTHERA Biopharmaceuticals Inc. (KYTH) said Monday it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of $100 million. All of the shares to be sold in the offering will be offered by KYTHERA.

KYTHERA intends to use the net proceeds of the offering to fund the ongoing development and preparation for potential commercialization of ATX-101, including the preparation and submission of its New Drug Application, or NDA, for ATX-101, and the balance for working capital and general corporate purposes, including research and development.